Loading organizations...
§ Private Profile · St Louis, MO, USA
Empowering genomic sequencing for cancer diagnosis and treatment.
PierianDx has raised $66.3M across 3 funding rounds.
PierianDx has raised $66.3M in total across 3 funding rounds.
PierianDx has raised $66.3M across 3 funding rounds. Most recently, it raised $30.0M Other Equity in November 2021.
| Date | Round | Lead Investors | Other Investors | Status |
|---|---|---|---|---|
| Nov 2, 2021 | $30M Venture Round | OrbiMed | ATW Partners, Health Catalyst Capital, Inova Health System, RTI International, SJF Ventures | Announced |
| Oct 28, 2019 | $27M Series B | Kerry Propper, SJF Ventures | ARUP Laboratories, Health Catalyst Capital, Inova Health System, RTI International | Announced |
| Jan 7, 2016 | $9.3M Series A | Charles Boorady | ARUP Laboratories, Inova Translational Medicine Institute, Ocean Road | Announced |
PierianDx has raised $66.3M in total across 3 funding rounds.
PierianDx's investors include OrbiMed, ATW Partners, Health Catalyst Capital, Inova Health System, RTI International, SJF Ventures, Kerry Propper, ARUP Laboratories, Charles Boorady, Inova Translational Medicine Institute, Ocean Road.